Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Xencor, Inc.
Xencor, Inc.
Nuvectis Pharma, Inc.
Pfizer
Tizona Therapeutics, Inc
A2 Biotherapeutics Inc.
Takeda
Adela, Inc
Second Life Therapeutics
Elephas
Novartis
Kura Oncology, Inc.
Elephas
AstraZeneca
Coherus Oncology, Inc.
Massive Bio, Inc.
7 Hills Pharma, LLC
A2 Biotherapeutics Inc.
A2 Biotherapeutics Inc.
Genentech, Inc.
Apollomics Inc.
ModeX Therapeutics, An OPKO Health Company
DEKA Biosciences
Tempus AI
Elevation Oncology
Pfizer
Nimbus Therapeutics
Astellas Pharma Inc
Actuate Therapeutics Inc.
Inhibrx Biosciences, Inc
Celldex Therapeutics
AO GENERIUM
Aurigene Discovery Technologies Limited
Corvus Pharmaceuticals, Inc.
Kineta Inc.
AvenCell Therapeutics, Inc.
Bristol-Myers Squibb
Quadriga Biosciences, Inc.
Exact Sciences Corporation
Syndax Pharmaceuticals
Pfizer
Novartis
Syndax Pharmaceuticals
Bristol-Myers Squibb
SpeciCare
Celgene
Amgen
Celldex Therapeutics
Amgen
GlaxoSmithKline
Amgen